MetaCap

Foghorn Therapeutics Inc. Company Profile

NASDAQ: FHTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.09+0.12 (+6.09%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Foghorn Therapeutics at a glance

Foghorn Therapeutics Inc. (NASDAQ: FHTX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2020. At a market capitalization of $124.1 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001822462, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

Company information

Legal name
Foghorn Therapeutics Inc.
Ticker
NASDAQ: FHTX
Industry
Biotechnology: Pharmaceutical Preparations
Headquarters
United States
IPO year
2020
Market cap
$124.12M
SEC CIK
0001822462

Companies similar to Foghorn Therapeutics

FHTX peer companies
CompanyPrice% ChgMarket capCompare
BGMBGM Group Ltd. Class A9.39-2.49%$125.40Mvs FHTX
NRXPNRX Pharmaceuticals Inc.2.90-1.36%$125.56Mvs FHTX
VTVTvTv Therapeutics Inc. Class A31.01+3.26%$122.61Mvs FHTX
HURATuHURA Biosciences Inc.1.98+1.54%$126.18Mvs FHTX
SPRBSpruce Biosciences Inc.44.40+3.77%$127.61Mvs FHTX
QUCYQuantum Cyber N.V.1.43+10.85%$120.22Mvs FHTX
INOInovio Pharmaceuticals Inc.1.16+2.21%$119.42Mvs FHTX
TNXPTonix Pharmaceuticals Holding Corp.7.55-1.88%$129.49Mvs FHTX

Related